St. Joseph's Hospital is a 253-bed hospital in downtown St. Paul, Minnesota. It is one of three tertiary hospitals located in St. Paul and is the oldest hospital in Minnesota. It is part of M Health Fairview.

There are 253 beds in Saint Joseph's Hospital - Healtheast.

During the past decade, Saint Joseph's Hospital - Healtheast conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 41 clinical trials were completed, i.e. on average, 256.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph's Hospital - Healtheast" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Boston Scientific Corporation" with 13 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph's Hospital - Healtheast" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph's Hospital - Healtheast" are "Breast Cancer" (8 trials), "Atrial Fibrillation" (6 trials), "Coronary Artery Disease" (5 trials), "Lung Cancer" (4 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Saint Joseph's Hospital - Healtheast" in a lesser frequency.

Most popular intervention types in "Saint Joseph's Hospital - Healtheast" are "Drug" (57 trials), "Device" (25 trials), "Other" (20 trials), "Biological" (16 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Bevacizumab" (8 trials), "Placebo" (5 trials), "Quality-of-Life Assessment" (5 trials) and "bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph's Hospital - Healtheast" are 72 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph's Hospital - Healtheast". undefined are not yet recruiting, 1 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Saint Joseph's Hospital - Healtheast, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph's Hospital - Healtheast, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 20 trials that are defined as “Not Applicable".